US Broker Ratings

CONMED Corporation (CNMD) Stock Analysis: Unlocking a 40% Upside Potential in the Medical Devices Sector

CONMED Corporation (CNMD), a key player in the healthcare sector, primarily focuses on developing and manufacturing medical devices used in various surgical procedures. With a market capitalization of $1.34 billion,..

LifeStance Health Group, Inc. (LFST) Investor Outlook: A 64.94% Potential Upside Awaits in the Mental Health Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) has been making waves in the healthcare sector, particularly within the outpatient mental health services industry. Based in Scottsdale, Arizona, the company has quickly..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Biotechnology Innovator with a 19% Upside Potential

For investors seeking exposure to cutting-edge biotechnology, CRISPR Therapeutics AG (NASDAQ: CRSP) presents a compelling opportunity. As a leader in gene editing, the company is pioneering transformative therapies using its..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Potential 58% Upside with Strong Buy Ratings

CG Oncology, Inc. (CGON), a promising player in the biopharmaceutical landscape, is capturing investor attention with its avant-garde approach to bladder cancer treatment. This Irvine, California-based company, with a market..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 28% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) stands as a compelling prospect in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $3.06 billion,..

Veracyte, Inc. (VCYT) Investor Outlook: Unlocking a 19.54% Upside with Robust Diagnostic Innovations

Veracyte, Inc. (NASDAQ: VCYT), a key player in the healthcare sector, operates within the diagnostics and research industry. The company, headquartered in South San Francisco, California, boasts a market capitalization..

DENTSPLY SIRONA Inc. (XRAY) Stock Report: Exploring a 33% Potential Upside Amidst Healthcare Innovations

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing investor attention with its robust dividend yield and a..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Potential 172.17% Upside Awaits Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) is garnering significant attention from investors, and for good reason. The clinical-stage biopharmaceutical company, based in San Diego, California, is on the cutting edge of..

Clover Health Investments (CLOV) Stock Analysis: Revenue Growth Shines Amidst Volatility

Clover Health Investments, Corp. (NASDAQ: CLOV), a player in the healthcare plans industry, has been drawing attention with its impressive revenue growth, despite some mixed signals in its financial metrics...

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Challenges with a 3% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the health information services industry, is attracting interest from investors with its compelling dividend yield of 3%. As a healthcare improvement company,..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 44% Upside Potential in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology company, emerges as a compelling opportunity for investors seeking exposure to the healthcare sector’s innovative landscape. With a market capitalization of $3.01..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unveiling a Potential 69% Upside for Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands as a key player in the biotechnology sector, with a market capitalization of $1.52 billion. The company, headquartered in Plymouth Meeting, Pennsylvania, is..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 130% Upside Potential in the Biotechnology Sector

Immunovant, Inc. (NASDAQ: IMVT), a New York-based biotechnology company, is catching the attention of investors with its promising pipeline in the autoimmune disease treatment space. As a clinical-stage immunology company,..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the Biotech Waters with a 4.25% Upside Potential

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its innovative therapies aimed at combating cancers, chronic hepatitis B..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Investor Outlook: Exploring a Potential 34% Upside

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a biopharmaceutical innovator based in the United Kingdom, is drawing attention in the healthcare sector with its promising product pipeline and robust revenue growth. With..

HUTCHMED (China) Limited (HCM) Stock Analysis: Unveiling a 46% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (HCM), a burgeoning player in the healthcare sector, presents an intriguing opportunity for investors looking to tap into the dynamic field of drug development and specialty pharmaceuticals...

Privia Health Group, Inc. (PRVA) Stock Analysis: Navigating a 25.80% Potential Upside

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, has been garnering attention from investors with its innovative approach to healthcare delivery and management. As a..

Ligand Pharmaceuticals (LGND) Investor Outlook: Analyzing Growth Potential and Analyst Confidence

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a noteworthy player in the biotechnology sector, capturing investor attention with its strategic focus on developing and licensing biopharmaceutical assets. With a market..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with a 19.64% Upside Potential

Warby Parker Inc. (NYSE: WRBY) is a standout in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its innovative approach to eyewear, Warby Parker has..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A 40% Potential Upside in the Biotech Arena

Investors with an eye on the biotech sector may find Scholar Rock Holding Corporation (NASDAQ: SRRK) a compelling opportunity, given its projected potential upside of 40.84%. This Cambridge-based biopharmaceutical company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds